New drug combo tested for Tough-to-Treat blood cancer
NCT ID NCT04094961
Summary
This study is testing a new combination of three drugs (ixazomib, pomalidomide, and dexamethasone) for people with multiple myeloma that has come back or stopped responding to prior treatments. The main goals are to find the safest dose of this combination and to see how well it works at controlling the cancer. It is for adults who have already tried at least one or two other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.